[CRL] Charles River Laboratories International, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Commercial Physical & Biological Resarch

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 75.72 Change: 1.37 (1.84%)
Ext. hours: Change: 0 (0%)

chart CRL

Refresh chart

Strongest Trends Summary For CRL

CRL is in the long-term up 28% above S&P in 1 year and up 116% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates through two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment produces and sells research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, and research animal diagnostic services; endotoxin and microbial detection products and services; and avian vaccine products and services. The PCS segment provides preclinical services, including in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program manage

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -6.09% Sales Growth - Q/Q-2.77% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA6.9% ROE18.39% ROI8.26%
Current Ratio2.27 Quick Ratio1.95 Long Term Debt/Equity2.2 Debt Ratio0.39
Gross Margin36.67% Operating Margin13.72% Net Profit Margin9.67% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-63.73 M Cash From Investing Activities-36.49 M Cash From Operating Activities96.68 M Gross Profit132.78 M
Net Profit48.51 M Operating Profit55.73 M Total Assets1.89 B Total Current Assets629.65 M
Total Current Liabilities276.53 M Total Debt772.77 M Total Liabilities1.18 B Total Revenue339.57 M
Technical Data
High 52 week145.31 Low 52 week98.19 Last close145.31 Last change0.44%
RSI90.47 Average true range2.96 Beta0.73 Volume208.32 K
Simple moving average 20 days10.55% Simple moving average 50 days18.73% Simple moving average 200 days20.35%
Performance Data
Performance Week3.16% Performance Month23.13% Performance Quart17.62% Performance Half20.5%
Performance Year45.65% Performance Year-to-date28.39% Volatility daily1.69% Volatility weekly3.79%
Volatility monthly7.76% Volatility yearly26.9% Relative Volume241.93% Average Volume404.31 K
New High New Low

News

2019-04-12 11:52:03 | Top Ranked Growth Stocks to Buy for April 12th

2019-04-12 10:32:02 | Teladoc's Partnership to Form Pediatric Telehealth Platform

2019-04-11 08:30:00 | Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference Call

2019-04-09 10:48:34 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-04-09 08:00:00 | Charles River Laboratories and CHDI Foundation Extend Huntington’s Disease Collaboration

2019-04-05 10:00:02 | Charles River Laboratories CRL Is Up 2.99% in One Week: What You Should Know

2019-04-04 10:41:02 | Zacks.com featured highlights include: Cadence Design, LPL, Charles and Automatic Data

2019-04-03 09:19:01 | 4 GARP Stocks for a Winning Portfolio

2019-04-02 11:53:39 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-04-02 10:27:02 | Top Ranked Growth Stocks to Buy for April 2nd

2019-04-02 09:15:01 | Charles River CRL Hits 52-Week High, Can the Run Continue?

2019-03-26 08:22:58 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-03-26 08:00:00 | Charles River Laboratories Highlights Commitment to Oncology Research at 2019 AACR Annual Meeting

2019-03-25 07:40:05 | Report: Developing Opportunities within Bristol-Myers Squibb, AutoNation, FirstEnergy, Charles River Laboratories International, Yum! Brands, and AGNC Investment — Future Expectations, Projections Moving into 2019

2019-03-15 10:00:59 | At US$141, Is It Time To Put Charles River Laboratories International, Inc. NYSE:CRL On Your Watch List?

2019-03-15 09:17:01 | Encouraging Near-Term Outlook for Medical Services Industry

2019-03-12 10:28:29 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-03-04 14:35:00 | Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

2019-03-04 09:20:02 | The Zacks Analyst Blog Highlights: General Motors, Charles River, DSW, Shoe Carnival and Boingo

2019-03-04 08:30:00 | Charles River Laboratories to Present at Raymond James and Barclays Investor Conferences

2019-03-01 07:05:12 | US Economy Had a Banner 2018: Top 5 Gainers

2019-02-27 09:57:02 | The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris

2019-02-27 08:52:00 | Charles River Laboratories Could Suffer a Pullback Before Moving Still Higher

2019-02-26 19:35:06 | Cramer Remix: This tech stock is worth buying ahead of the 5G rollout

2019-02-26 19:08:06 | Charles River Laboratories CEO: The drug industry is benefiting from biotech and pharma

2019-02-26 08:55:01 | 4 Drug Stocks to Buy Despite Price Hearing Woes

2019-02-25 09:15:02 | Charles River CRL Hits Fresh High: Is There Still Room to Run?

2019-02-23 08:40:17 | What Are Analysts Saying About Charles River Laboratories International, Inc.’s NYSE:CRL Growth?

2019-02-14 13:17:07 | Charles River Laboratories Int'l, Inc. -- Moody's says Charles River's acquisition of Citoxlab is credit negative

2019-02-14 10:02:49 | Smart medicine: AI plays an increasingly bigger role in health care

2019-02-13 19:16:00 | Charles River Laboratories International Inc CRL Q4 2018 Earnings Conference Call Transcript

2019-02-13 17:17:18 | Edited Transcript of CRL earnings conference call or presentation 13-Feb-19 1:30pm GMT

2019-02-13 08:20:01 | Charles River Laboratories CRL Q4 Earnings and Revenues Surpass Estimates

2019-02-13 07:28:17 | Charles River: 4Q Earnings Snapshot

2019-02-13 07:01:00 | Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance

2019-02-13 07:00:00 | Charles River Laboratories Signs Binding Offer to Acquire Citoxlab

2019-02-08 08:04:46 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-02-06 10:30:03 | Earnings Preview: Charles River Laboratories CRL Q4 Earnings Expected to Decline

2019-01-31 07:46:42 | Need To Know: Charles River Laboratories International, Inc. NYSE:CRL Insiders Have Been Selling Shares

2019-01-30 08:00:00 | Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North America

2019-01-29 08:04:55 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-01-22 08:03:36 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-01-18 07:25:00 | Consolidated Research: 2019 Summary Expectations for Electronic Arts, Charles River Laboratories International, Cooper-Standard, Five Below, Emerge Energy Services LP, and Hornbeck Offshore Services — Fundamental Analysis, Key Performance Indications

2019-01-17 08:30:00 | Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference Call

2019-01-16 08:00:00 | Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality Index

2019-01-11 08:00:00 | Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery

2019-01-09 08:05:13 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-01-09 06:50:00 | Today's Research Reports on Trending Tickers: Syneos Health and Charles River Laboratories International

2019-01-08 10:30:54 | What Did Charles River Laboratories International, Inc.’s NYSE:CRL CEO Take Home Last Year?

2019-01-07 08:00:00 | Charles River Laboratories to Present at J.P. Morgan Healthcare Conference